Flash news!! Found medicine for corona anta

[veeraveeraleaks]

ani news petti biscuit chesina incidents oh pari rewind sesukundham aaaa  

1] malaria drug from thatha

2] Paracetomol from dhora and jagan

3] Edho plasma treatment from netflix lo vacche guy

4] Johnson and Johnson

5] Gilead

6] Oxford university lo edho love daaaa.

 

Ekkada saccharu ra ippudu andaru....Cure devudu ergu kanisam on the way ani hope kuda ivvatle...

 

University Degrees Online

Get the education you need to reach the next level of your career

www.degreenexus.com

 

[quickgun_murugun]

New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. 

[quickgun_murugun]

https://www.statnews.com/2020/04/23/data-on-gileads-remdesivir-released-by-accident-show-no-benefit-for-coronavirus-patients/

[Pitta]

esko 

[quickgun_murugun]

APRIL 23, 2020

 

 

Bottles of remdesivir in a hospital for Covid-19 patients in Wuhan, China.FEATURECHINA VIA AP

The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from dying, according to results from a long-awaited clinical trial conducted in China. Gilead, however, said the data suggest a “potential benefit.”

A summary of the study results was inadvertently posted to the website of the World Health Organization and seen by STAT on Thursday, but then removed.

“A draft document was provided by the authors to WHO and inadvertently posted on the website and taken down as soon as the mistake was noticed. The manuscript is undergoing peer review and we are waiting for a final version before WHO comments,” said WHO spokesperson Tarik Jasarevic.

Gilead spokesperson Amy Flood said the company believes “the post included inappropriate characterization of the study.” Because the study was stopped early because it had too few patients, she said, it cannot “enable statistically meaningful conclusions.” However, she said, “trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease.”

The data (for details, see screenshot below) will be closely scrutinized but are also likely imperfect. The study was terminated prematurely, which could have affected the results. The context that would be provided by a full manuscript is missing, and the data have not been reviewed as normally occurs before publication.

[MagaMaharaju]

Just now, quickgun_murugun said:

https://www.statnews.com/2020/04/23/data-on-gileads-remdesivir-released-by-accident-show-no-benefit-for-coronavirus-patients/

Hopeless 😩 

[quickgun_murugun]

Just now, MagaMaharaju said:

Hopeless 😩 

Gilead still sees reason for hope

[nightkalalu]

Gilead says coronavirus drug may still benefit patients
 

https://www.cnbc.com/2020/04/22/dow-futures-steady-as-investors-digest-oil-turbulence-await-jobless-claims.html

[veeraveeraleaks]

1 minute ago, quickgun_murugun said:

Gilead still sees reason for hope

Hope can save lives?

[MagaMaharaju]

1 minute ago, quickgun_murugun said:

Gilead still sees reason for hope

[quickgun_murugun]

Just now, veeraveeraleaks said:

Hope can save lives?

Nope... can raise their stocks

[MagaMaharaju]

Just now, veeraveeraleaks said:

Hope can save lives?

To some extent willpower can fight death 

[MagaMaharaju]

Just now, quickgun_murugun said:

Nope... can raise their stocks

[Somedude]

4 minutes ago, quickgun_murugun said:

Gilead still sees reason for hope

 

3 minutes ago, nightkalalu said:

Gilead says coronavirus drug may still benefit patients
 

https://www.cnbc.com/2020/04/22/dow-futures-steady-as-investors-digest-oil-turbulence-await-jobless-claims.html

Half hour back Financial Times lo choosa. I can't paste the whole thing here. Hopeless. They studied 237 patients giving the drug to 158 comparing their progress with remaining 79. No difference.

Gilead Sciences's (GILD) Antiviral Drug Remdesivir Flops in First trial - FT

[veeraveeraleaks]

1 minute ago, quickgun_murugun said:

Nope... can raise their stocks